Topline Results of a Phase 2 Study of Subcutaneous IMVT-1401 in Patients with Generalized Myasthenia Gravis

被引：0
|
作者：
Benatar, Michael [1 ]
Breiner, Ari [2 ]
Bril, Vera [3 ]
Nowak, Richard [4 ]
Dunn, Imogene [5 ]
Jacobs, Alan [5 ]
机构：
[1] Univ Miami, Coral Gables, FL 33124 USA
[2] Ottawa Hosp, Civ Campus, Ottawa, ON, Canada
[3] Toronto Gen Hosp, Toronto, ON, Canada
[4] Yale Univ, Sch Med, New Haven, CT 06520 USA
[5] Immunovant Inc, New York, NY USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1417
引用
收藏
页数：4
相关论文
共 50 条
  • [41] LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
    Howard, James
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Mantegazza, Renato
    MUSCLE & NERVE, 2022, 66 : S57 - S57
  • [42] Response to zilucoplan in the Phase 3 RAISE study in patients with generalised myasthenia gravis
    Mantegazza, R.
    Bresch, S.
    Freimer, M.
    Hewamadduma, C.
    Leite, M.
    Maniaol, A.
    Schmidt, J.
    Utsugisawa, K.
    Vu, T.
    Boroojerdi, B.
    Lejdstrom, R. Beau
    Duda, P.
    Grimson, F.
    Savic, N.
    Howard, J., Jr.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 207 - 208
  • [43] LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
    Howard, James F., Jr.
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    MUSCLE & NERVE, 2022, 65 : S9 - S10
  • [44] REAL-WORLD EFFECTIVENESS OF ECULIZUMAB IN BLACK PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS IN THE US: RESULTS FROM A RETROSPECTIVE OBSERVATIONAL STUDY
    Morgan, Marla
    Habib, Ali A.
    Nowak, Richard J.
    Muppidi, Srikanth
    Parthan, Anju
    Kielhorn, Adrian
    Wang, Jane
    Howard, James F., Jr.
    MUSCLE & NERVE, 2022, 66 : S126 - S126
  • [45] Efficacy and safety of Efgartigimod in patients with generalized myasthenia gravis: interim results of a prospective, single-arm, observational study in China
    Liang, H.
    Wang, P.
    Zhang, B.
    Zhao, C.
    Huang, S.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S177 - S177
  • [46] A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
    Howard, James F., Jr.
    Barohn, Richard J.
    Cutter, Gary R.
    Freimer, Miriam
    Juel, Vern C.
    Mozaffar, Tahseen
    Mellion, Michelle L.
    Benatar, Michael G.
    Farrugia, Maria Elena
    Wang, Jing Jing
    Malhotra, Suneil S.
    Kissel, John T.
    MUSCLE & NERVE, 2013, 48 (01) : 76 - 84
  • [47] Adverse Side Effects Associated with Corticosteroid Therapy: A Study in 39 Patients with Generalized Myasthenia Gravis
    Johnson, Stephen
    Katyal, Nakul
    Narula, Naureen
    Govindarajan, Raghav
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [48] Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study
    Pasnoor, Mamatha
    Bril, Vera
    Levine, Todd
    Trivedi, Jaya
    Silvestri, Nicholas J.
    Phadnis, Milind
    Katzberg, Hans D.
    Saperstein, David S.
    Wolfe, Gil I.
    Herbelin, Laura
    Higgs, Kiley
    Heim, Andrew J.
    Statland, Jeffrey M.
    Barohn, Richard J.
    Dimachkie, Mazen M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (05) : 1417 - 1424
  • [49] Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients
    Wang, Pan
    Zhang, Bo
    Yin, Jian
    Xi, Jianying
    Tan, Ying
    Gao, Feng
    Zeng, Fan
    Chang, Ting
    Zhou, Hao
    Liang, Hui
    Zhao, Zhongyan
    Yang, Huan
    Zhao, Chongbo
    Huang, Shixiong
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [50] Efficacy of Rozanolixizumab in Generalized Myasthenia Gravis: Subgroup Analyses from the Randomized Phase 3 MycarinG Study
    Vu, Tuan
    Druzdz, Artur
    Grosskreutz, Julian
    Habib, Ali A.
    Kaminski, Henry J.
    Mantegazza, Renato
    Utsugisawa, Kimiaki
    Vissing, John
    Beau-Lejdstrom, Raphaelle
    Boehnlein, Marion
    Gasalla, Teresa
    Grimson, Fiona
    Tarancon, Thais
    Bril, Vera
    NEUROLOGY, 2023, 100 (17)
12345